A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation

NCT05557409 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

408

Enrollment

INDUSTRY

Sponsor class

Conditions

Agitation in Patients With Dementia of the Alzheimer's Type
Alzheimer Disease
Agitation

Interventions

DRUG: AXS-05
DRUG: Placebo

Sponsor

Axsome Therapeutics, Inc.